Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186536 | 0.93 | TSHR (0.43) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL8943827 | 0.91 | ALDH1A1 (0.44) | TSHRACHECYP3A4ALDH1A1MAPT | |
| Phosphine SCHEMBL28302574 | 0.91 | TSHR (0.41) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL17734750 | 0.90 | CYP3A4 (0.33) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL12551587 | 0.89 | TRPM8 (0.36) | TSHRCYP3A4HDAC6LMNATRPM8 | |
| SCHEMBL3513273 | 0.89 | TSHR (0.39) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL3477596 | 0.89 | ALDH1A1 (0.48) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL29372483 | 0.89 | ACHE (0.43) | TSHRACHECYP3A4ALDH1A1TDP1 | |
| SCHEMBL8470149 | 0.89 | TSHR (0.43) | TSHRACHECYP3A4ALDH1A1MAPT | |
| SCHEMBL312994 | 0.89 | ACHE (0.43) | TSHRACHECYP3A4ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1696709-B1 | ORGANO-ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | NIPPON STEEL CHEMICAL CO (JP) | 2012-10-24 | — | — | EP | disclosed |
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| US-7629059-B2 | Organo-electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20090066222-A1 | Organic electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| EP-1826837-A1 | ORGANIC ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | Bando Chemical Industries, Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7196224-B2 | 1,3,5-tris(arylamino)benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20070066848-A1 | Organo-electronic functional material and use thereof | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-1696709-A1 | ORGANO-ELECTRONIC FUNCTIONAL MATERIAL AND USE THEREOF | Bando Chemical Industries, Ltd. (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066848-A1 | Organo-electronic functional material and use thereof | SLCO2A1, SLCO2B1, KCNN2 | TSHR 2079/4885ACHE 2338/4885CYP3A4 436/4885 |
| US-20090066222-A1 | Organic electronic functional material and use thereof | EFNA1, EPB41, ETFB | TSHR 4769/4885ACHE 1656/4885CYP3A4 211/4885 |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | TSHR 3997/4885ACHE 2644/4885CYP3A4 395/4885 |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | AHR, MYB, NAP1L4 | TSHR 3436/4885ACHE 2774/4885CYP3A4 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.